We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App

Non-Invasive Medical Imaging Test Predicts Dementia Nine Years before Diagnosis

By MedImaging International staff writers
Posted on 12 Jun 2024
Print article
Image: The first-of-its-kind test predicts dementia with over 80% accuracy and up to nine years before diagnosis (Photo courtesy of Queen Mary University of London)
Image: The first-of-its-kind test predicts dementia with over 80% accuracy and up to nine years before diagnosis (Photo courtesy of Queen Mary University of London)

Predicting future cases of dementia is crucial for developing interventions aimed at preventing the irreversible loss of brain cells responsible for dementia symptoms. While advancements have been made in identifying brain proteins linked to Alzheimer’s disease, many individuals carry these proteins for years without exhibiting dementia symptoms. Currently, dementia is commonly diagnosed through memory tests or by measuring brain shrinkage. Now, a newly developed method offers over 80% accuracy in predicting dementia up to nine years before an official diagnosis, providing a more precise approach to early identification.

Researchers at Queen Mary University of London (London, UK) developed this predictive test by analyzing functional MRI (fMRI) scans to assess changes in the brain’s ‘default mode network’ (DMN), which is essential for cognitive functions and is the first neural network impacted by Alzheimer’s disease. Utilizing fMRI scans from more than 1,100 volunteers from the UK Biobank—a comprehensive biomedical database containing health and genetic information from half a million UK participants—the team evaluated the effective connectivity among ten brain regions that make up the DMN. Each participant was assigned a probability of developing dementia based on how closely their connectivity patterns matched those typically seen in dementia versus control-like patterns.

The predictions were then matched against the medical records of the participants from the UK Biobank. Results demonstrated that the model could accurately forecast the onset of dementia up to nine years before it was officially diagnosed, with an accuracy rate exceeding 80%. For those who eventually developed dementia, the model was also able to predict, within a two-year margin of error, the timeline until diagnosis. Further investigations by the researchers explored whether alterations to the DMN could be attributed to known dementia risk factors. Their findings indicated that genetic predispositions to Alzheimer’s disease strongly correlated with connectivity changes in the DMN, reinforcing the notion that these alterations are specific to Alzheimer’s. Additionally, they noted that social isolation could increase dementia risk due to its impact on DMN connectivity.

“Using these analysis techniques with large datasets we can identify those at high dementia risk, and also learn which environmental risk factors pushed these people into a high-risk zone. Enormous potential exists to apply these methods to different brain networks and populations, to help us better understand the interplays between environment, neurobiology and illness, both in dementia and possibly other neurodegenerative diseases,” said Samuel Ereira, lead author and Academic Foundation Program Doctor at the Centre for Preventive Neurology, Wolfson Institute of Population Health. “fMRI is a non-invasive medical imaging tool, and it takes about 6 minutes to collect the necessary data on an MRI scanner, so it could be integrated into existing diagnostic pathways, particularly where MRI is already used.”

Related Links:
Queen Mary University of London

Gold Member
Solid State Kv/Dose Multi-Sensor
CT Phantom
CIRS Model 610 AAPM CT Performance Phantom
Portable Digital X-Ray System
Acuity PDR
Drape Barrier
Double Pivot Swing Arm Drape

Print article



view channel
Image: The new FDA-cleared AI-enabled applications have been integrated into the EPIQ CVx and Affiniti CVx ultrasound systems (Photo courtesy of Royal Philips)

Next-Gen AI-Enabled Cardiovascular Ultrasound Platform Speeds Up Analysis

Heart failure is a significant global health challenge, affecting approximately 64 million individuals worldwide. It is associated with high mortality rates and poor quality of life, placing a considerable... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Calantic Digital Solutions is an orchestrated suite of AI radiology solutions that aims to transform radiology (Photo courtesy of Bayer)

Bayer and Rad AI Collaborate on Expanding Use of Cutting Edge AI Radiology Operational Solutions

Imaging data constitutes approximately 90% of all medical data, with the volume of such data continuously expanding, thereby significantly increasing the workload for radiologists amid existing resource limitations.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.